Schucht Philippe, Knittel Sonja, Slotboom Johannes, Seidel Kathleen, Murek Michael, Jilch Astrid, Raabe Andreas, Beck Jürgen
Department of Neurosurgery, Inselspital, Bern University Hospital, Freiburgstrasse 10, 3010, Bern, Switzerland,
Acta Neurochir (Wien). 2014 Feb;156(2):305-12; discussion 312. doi: 10.1007/s00701-013-1906-7. Epub 2013 Oct 25.
The technique of 5-aminolevulinic acid (5-ALA) tumor fluorescence is increasingly used to improve visualization of tumor tissue and thereby to increase the rate of patients with gross total resections. In this study, we measured the resection volumes in patients who underwent 5-ALA-guided surgery for non-eloquent glioblastoma and compared them with the preoperative tumor volume.
We selected 13 patients who had received a complete resection according to intraoperative 5-ALA induced fluorescence and CRET according to post-operative T1 contrast-enhanced MRI. The volumes of pre-operative contrast enhancing tissue, post-operative resection cavity and resected tissue were determined through shift-corrected volumetric analysis.
The mean resection cavity (29 cm(3)) was marginally smaller than the pre-operative contrast-enhancing tumor (39 cm(3), p = 0.32). However, the mean overall resection volume (84 cm(3)) was significantly larger than the pre-operative contrast-enhancing tumor (39 cm(3), p = 0.0087). This yields a mean volume of resected 5-ALA positive, but radiological non-enhancing tissue of 45 cm(3). The mean calculated rim of resected tissue surpassed pre-operative tumor diameter by 6 mm (range 0-10 mm).
Results of the current study imply that (i) the resection cavity underestimates the volume of resected tissue and (ii) 5-ALA complete resections go significantly beyond the volume of pre-operative contrast-enhancing tumor bulk on MRI, indicating that 5-ALA also stains MRI non-enhancing tumor tissue. Use of 5-ALA may thus enable extension of coalescent tumor resection beyond radiologically evident tumor. The impact of this more extended resection method on time to progression and overall survival has not been determined, and potentially puts adjacent and functionally intact tissue at risk.
5-氨基乙酰丙酸(5-ALA)肿瘤荧光技术越来越多地用于改善肿瘤组织的可视化,从而提高大体全切患者的比例。在本研究中,我们测量了接受5-ALA引导手术的非功能区胶质母细胞瘤患者的切除体积,并将其与术前肿瘤体积进行比较。
我们选择了13例根据术中5-ALA诱导荧光进行了完整切除且根据术后T1增强MRI进行了CRET的患者。通过移位校正体积分析确定术前增强组织、术后切除腔和切除组织的体积。
平均切除腔(29 cm³)略小于术前增强肿瘤(39 cm³,p = 0.32)。然而,平均总切除体积(84 cm³)显著大于术前增强肿瘤(39 cm³,p = 0.0087)。这产生了平均45 cm³的切除的5-ALA阳性但影像学上未增强的组织体积。切除组织的平均计算边缘超过术前肿瘤直径6 mm(范围0-10 mm)。
本研究结果表明,(i)切除腔低估了切除组织的体积,(ii)5-ALA全切显著超出了MRI上术前增强肿瘤体积,表明5-ALA也能标记MRI上未增强的肿瘤组织。因此,使用5-ALA可能使融合性肿瘤切除范围超出影像学上明显的肿瘤。这种更广泛的切除方法对进展时间和总生存期的影响尚未确定,并且可能使相邻和功能完整的组织处于风险中。